搜索
您的当前位置:首页正文

USE OF CROSS-LINKED, COVALENTLY BOUND UROKINASE PL

来源:小奈知识网
专利内容由知识产权出版社提供

专利名称:USE OF CROSS-LINKED, COVALENTLY

BOUND UROKINASE PLASMINOGENACTIVATOR (SCUPA)-UROKINASEPLASMINOGEN ACTIVATOR RECEPTOR(SUPAR) COMPLEX AS A FIBRINOLYTICAGENT

发明人:HIGAZI, Abd.Al-Roof申请号:EP02749652.0申请日:20020624公开号:EP1423002A1公开日:20040602

摘要:The present invention relates to the cross-linked scuPA/suPAR complex and/ortcuPA/suPAR cross-linked complex, the process of preparation of the covalently boundsingle compound having fibrinolytic activity and use of the cross-linked scuPA/suPAR ortcuPA/suPAR complex in the prevention and/or treatment of thrombolytic disorders. Theinvention further relates to combination compositions and/or therapy regimens,comprising the cross-linked scuPA/suPAR complex or tcuPA/suPAR and one or morecurrently used plasminogen activators to achieve improved therapeutic efficacy and/orreduce side effects.

申请人:Thrombotech Ltd

地址:P.O. Box 732 17106 Nazareth Illit IL

国籍:IL

代理机构:Wittop Koning, Tom Hugo

更多信息请下载全文后查看

因篇幅问题不能全部显示,请点此查看更多更全内容

Top